{
    "2018-09-25": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Gilead (GILD) to Launch Generics for Leading HCV Treatments",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Generics",
                        "HCV",
                        "Launch"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Exploring Idexx Laboratoriesâ€™ Operational Performance",
                "features": {
                    "keywords": [
                        "Idexx",
                        "Laboratories",
                        "Operational",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "How Idexx Laboratories Is Positioned in 2018",
                "features": {
                    "keywords": [
                        "Idexx",
                        "Laboratories",
                        "Positioned",
                        "2018"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "ABBVIE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $500,000 Investing In AbbVie Inc. To Contact The Firm",
                "features": {
                    "keywords": [
                        "ABBVIE",
                        "Investor",
                        "Alert",
                        "Losses",
                        "Faruqi",
                        "&",
                        "Faruqi",
                        "LLP"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against AbbVie Inc. (ABBV)",
                "features": {
                    "keywords": [
                        "Gainey",
                        "McKenna",
                        "&",
                        "Egleston",
                        "Class",
                        "Action",
                        "Lawsuit",
                        "AbbVie"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}